Rob Lauzen is a seasoned finance professional with extensive experience in the biotechnology and investment banking sectors. Currently serving as Chief Financial Officer at Circle Pharma, Inc. since November 2025, Rob previously held the same position at Prilenia from September 2024 to November 2025. Prior to that, a significant tenure at Dyne Therapeutics was marked by roles as Vice President of Investor Relations and Head of FP&A, and as Senior Director of those departments from September 2021 to September 2024. Rob's early career includes multiple positions at Morgan Stanley, culminating in the role of Healthcare Investment Banking Vice President, as well as co-founding DiagnosMe LLC. Education was completed at Dartmouth College with a Bachelor of Arts in Engineering.
This person is not in any teams
This person is not in any offices